Cargando…

Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells

Most breast cancer-related deaths from triple-negative breast cancer (TNBC) occur following metastasis of cancer cells and development of tumors at secondary sites. Because TNBCs lack the three receptors targeted by current chemotherapeutic regimens, they are typically treated with extremely aggress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cook, Matthew T, Liang, Yayun, Besch-Williford, Cynthia, Hyder, Salman M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207335/ https://www.ncbi.nlm.nih.gov/pubmed/28096694 http://dx.doi.org/10.2147/BCTT.S124860

Ejemplares similares

APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude mice
por: Liang, Yayun, et al.
Publicado: (2019)

Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts
por: Cook, Matthew T., et al.
Publicado: (2015)

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
por: Liang, Yayun, et al.
Publicado: (2018)

SUN-LB055 Targeting Mutant p53 Alone or in Combination with a Phosphatidylserine Specific Antibody Suppresses Growth and Metastasis of Human Breast Cancer: A Strategy Towards Enhancing Personalized Medicine
por: Liang, Yayun, et al.
Publicado: (2019)

The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development
por: CARROLL, CANDACE E., et al.
Publicado: (2012)

Inhibiting Growth of Human Triple-Negative Breast Cancer Cells by Activating Mutant p53 Protein Alone or in Combination With a Phosphatidylserine-Targeting Antibody
por: Liang, Yayun, et al.
Publicado: (2021)

Reduction in milk fat globule-EGF factor 8 inhibits triple-negative breast cancer cell viability and migration
por: Yang, Yong, et al.
Publicado: (2019)

Mechanism of metastasis suppression by luteolin in breast cancer
por: Cook, Matthew T
Publicado: (2018)

Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer
por: Berke, Taylor P, et al.
Publicado: (2022)

Zinc complex of 3,5-di-tert-butyl salicylate inhibits viability, migration, and invasion in triple-negative breast cancer cells
por: Chen, Heng, et al.
Publicado: (2022)

Luteolin Inhibits Vascular Smooth Muscle Cell Proliferation and Migration by Inhibiting TGFBR1 Signaling
por: Wu, Yu-Ting, et al.
Publicado: (2018)

Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells
por: Liang, Yayun, et al.
Publicado: (2017)

Luteolin inhibits A549 cells proliferation and migration by down-regulating androgen receptors
por: Li, Xu, et al.
Publicado: (2023)

THU542 Inhibiting Oxidosqualene Cyclase Suppresses Cancer Stem-like Cells And Growth Of Epithelial Ovarian Cancer Cells In Vitro And In Vivo
por: Liang, Yayun, et al.
Publicado: (2023)

Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis
por: Mullen, McKay, et al.
Publicado: (2021)

EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer
por: Liu, Xia, et al.
Publicado: (2021)

Differential effects of luteolin and its glycosides on invasion and apoptosis in MDA-MB-231 triple-negative breast cancer cells
por: Lee, Jiyon, et al.
Publicado: (2019)

HC-1119, a deuterated Enzalutamide, inhibits Migration, Invasion and Metastasis of the AR-positive triple-negative breast Cancer cells
por: Wu, Xuehong, et al.
Publicado: (2022)

Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro
por: Goyette, Sandy, et al.
Publicado: (2017)

Luteolin Ameliorates Hypertensive Vascular Remodeling through Inhibiting the Proliferation and Migration of Vascular Smooth Muscle Cells
por: Su, Jie, et al.
Publicado: (2015)

Arctigenin Inhibits Lung Metastasis of Colorectal Cancer by Regulating Cell Viability and Metastatic Phenotypes
por: Han, Yo-Han, et al.
Publicado: (2016)

Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells
por: Bar, Isabelle, et al.
Publicado: (2018)

Formulation and Evaluation of Luteolin-Loaded Nanovesicles: In Vitro Physicochemical Characterization and Viability Assessment
por: Imam, Syed Sarim, et al.
Publicado: (2021)

MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer
por: Hou, Lingmi, et al.
Publicado: (2016)

Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling
por: Shahi Thakuri, Pradip, et al.
Publicado: (2020)

Luteolin inhibits triple-negative breast cancer by inducing apoptosis and autophagy through SGK1-FOXO3a-BNIP3 signaling
por: Wu, Ling, et al.
Publicado: (2023)

Inhibitory Effects and Mechanisms of Luteolin on Proliferation and Migration of Vascular Smooth Muscle Cells
por: Jiang, Dehua, et al.
Publicado: (2013)

Flavonoids Luteolin and Quercetin Inhibit RPS19 and contributes to metastasis of cancer cells through c-Myc reduction
por: Chen, Ku-Chung, et al.
Publicado: (2018)

Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells
por: Zhao, Zhijing, et al.
Publicado: (2018)

Inhibition of miR-214 attenuates the migration and invasion of triple-negative breast cancer cells
por: Zhang, Yi, et al.
Publicado: (2019)

AB186 Inhibits Migration of Triple-Negative Breast Cancer Cells and Interacts with α-Tubulin
por: Geoffroy, Marine, et al.
Publicado: (2022)

MUC4 Overexpression Augments Cell Migration and Metastasis through EGFR Family Proteins in Triple Negative Breast Cancer Cells
por: Mukhopadhyay, Partha, et al.
Publicado: (2013)

Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells
por: Ismail, Thamir M., et al.
Publicado: (2023)

Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
por: Zhao, Zhonghe, et al.
Publicado: (2021)

Identification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening
por: Xu, Lin, et al.
Publicado: (2014)

Atorvastatin Inhibits Viability and Migration of MCF7 Breast Cancer Cells
por: Abolghasemi, Reyhaneh, et al.
Publicado: (2022)

ELOVL2-AS1 inhibits migration of triple negative breast cancer
por: Zhu, Mingda, et al.
Publicado: (2022)

Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells
por: Bilir, Birdal, et al.
Publicado: (2013)

Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4
por: Grottke, Astrid, et al.
Publicado: (2016)

Luteolin Inhibits Angiotensin II-Stimulated VSMC Proliferation and Migration through Downregulation of Akt Phosphorylation
por: Xu, Tongda, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lm08kfg3a9lch60po4njsk20j6